Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
Hiddo J Lambers HeerspinkRajiv AgarwalGeorge L BakrisDavid Z I CherneyCarolyn S P LamBrendon L NeuenPantelis A SarafidisKatherine R TuttleChristoph WannerMeike D BrinkerSara DizayeePeter KolkhofPatrick SchloemerPaula VesterinenVlado Perkovicnull nullPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)
FIND-CKD is the first Phase 3 trial of finerenone in patients with CKD of non-diabetic aetiology.